02/07/2025
3:30 PM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 4/A | |
01/13/2025
7:00 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:05 AM | Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:05 AM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
4:30 PM | Akari Therapeutics (Issuer)
Neal James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:30 PM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:30 PM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AKTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2024
3:30 PM | Akari Therapeutics (Issuer)
Neal James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:30 PM | Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
3:00 PM | Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
| Form SC 13D/A | |
12/03/2024
4:48 PM | Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:50 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:30 PM | Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2024
3:30 PM | Akari Therapeutics (Issuer)
Neal James R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/19/2024
3:48 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/18/2024
7:02 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:27 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:00 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
5:00 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:51 AM | Akari Therapeutics (Subject)
| Form 425 | |
10/14/2024
11:15 PM | Akari Therapeutics (Filer)
| Form EFFECT | |
10/11/2024
3:52 PM | Akari Therapeutics (Filer)
| Form 424B3 | |
10/09/2024
3:27 PM | Akari Therapeutics (Filer)
| Form S-4/A | |
10/04/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
5:34 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
5:43 AM | Akari Therapeutics (Filer)
| Form S-4/A | |
09/18/2024
3:34 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:36 PM | Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2024
3:40 PM | Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2024
11:15 PM | Akari Therapeutics (Filer)
| Form EFFECT | |
09/13/2024
4:30 PM | Akari Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
09/06/2024
4:23 PM | Akari Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
09/06/2024
4:07 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K/A | |
08/19/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:15 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:15 PM | Akari Therapeutics (Filer)
| Form NT 10-Q | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
WILLIAMS DONALD A (Reporting)
WILLIAMS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Hashad Mohamed Wa'el Ahmed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
6:30 AM | Akari Therapeutics (Subject)
RPC Pharma Ltd (Filed by)
| Form SC 13D/A | |
06/07/2024
5:00 PM | Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
| Form SC 13D | |
06/04/2024
3:45 PM | Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:45 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Akari Therapeutics (Subject)
| Form 425 | |
06/04/2024
7:02 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
7:05 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:47 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
4:27 PM | Akari Therapeutics (Subject)
| Form 425 | |
05/01/2024
4:04 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
8:45 PM | Akari Therapeutics (Issuer)
Jacques Rachelle Suzanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:30 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
5:30 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:15 PM | Akari Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
4:25 PM | Akari Therapeutics (Subject)
| Form 425 | |
03/11/2024
4:24 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:28 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:34 AM | Akari Therapeutics (Subject)
| Form 425 | |
